FDA's May 5, 2022 action restricting Janssen vaccine use because of TTS risk; the announcement reports 60 confirmed TTS cases including 9 deaths, a TTS rate of 3.23 per million doses and 0.48 deaths per million doses.
limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate
FDA's May 5, 2022 action restricting Janssen vaccine use because of TTS risk; the announcement reports 60 confirmed TTS cases including 9 deaths, a TTS rate of 3.23 per million doses and 0.48 deaths per million doses. the Oklahoma State Department of Health govdelivery bulletin reproduces the FDA announcement verbatim.